Inside information: Nightingale Health is investigating the transfer of its B shares to the Main Market of Nasdaq Helsinki and adding the OTCQX market as an additional trading venue in the U.S.
Nightingale Health PlcCompany releaseInside information27 November 2024 at 2:20 p.m. (EET) The Board of Directors of Nightingale Health Plc (“Nightingale Health”), a pioneer in disease risk detection and preventative health, has decided to investigate the possible transfer of the company’s publicly traded series B shares (the “Shares”) from Nasdaq First North Growth Market Finland to the main market of Nasdaq Helsinki Ltd (the “Main Market”) and the possible cross-trading of the Shares on the OTCQX market, managed by the OTC Markets Group Inc. (“OTC Markets”) in the United States.